Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
H&R GmbH & Co. KGaA
2HRAH&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts, components, and medical consumables for medical technology, automotive, and other traditional industries. It provides emulsifiers and bases, waxes and emulsions, petroleum jellies, water-based waxes and oil-emulsions, motor and process oils, cable filling compounds. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany Address: Neuenkirchener Strasse 8, Salzbergen, Germany, 48499
Analytics
Zielpreis von Wall Street
5.29 EURKGV
14.68Dividendenrendite
2.84 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 2HRA
Dividenden-Analyse 2HRA
Dividendenwachstum über 5 Jahre
-64 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
35 %Verlauf der Dividende 2HRA
Bewertung der Aktie 2HRA
Finanzen 2HRA
Ergebnisse | 2019 | Dynamik |